299
Views
16
CrossRef citations to date
0
Altmetric
Research papers

Cystic fibrosis transmembrane conductance regulator mutations and polymorphisms associated with congenital bilateral absence of vas deferens in a restricted group of patients from North Africa

, , , , , & show all
Pages 76-79 | Received 21 Jun 2011, Accepted 17 Nov 2011, Published online: 08 Dec 2011

References

  • Alonso M, Blanco A, Fernandez-Burriel M, Calleja J, Fernandez I, Sanz A, Valasco E, Telleria JJ. 2000. Poluvariant mutant genes: different haplotypes determining different alterations causing azoospermia. Gene Funct Dis. 5–6:189–193.
  • Casals T, Bassas L, Egozcue S, Ramos MD, Gimenez J, Segura A, Garcia F, Carrera M, Larriba S, Sarquella J, Estivill X. 2000. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of vas deferens. Hum Rep. 15:1476–1483.
  • Chih Wu C, Alper ÖM, Feng Lu J, Ping Wang S, Guo L, Sun Chiang H, Jun L, Wong C. 2005. Mutation spectrum of the CFTR gene in Taiwanese patients with congenital bilateral absence of the vas deferens. Hum Rep. 20:2470–2475.
  • Claustres M, Altieri JP, Guittard C, Templin C, Chevalier Prost F, Des Georges M. 2004. Are p.1148T, p.R74W and p.D1270N cystic fibrosis causing mutation?. BMC Med Genet. 5:19.
  • Dequeker E, Stuhrmann M, Morris MA, Casals T, Castellani C, Claustres M, Cuppens H, Des Georges M, Ferec C, Macek M, Pignatti PF, Schwartz M, Witt M, Schwarz M, Girodon E. 2009. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR- related disorders- updated European recommendations. Eur J Hum Genet. 17:51–65.
  • Desideri-Vaillant C, Creff J, Le Maréchal C, Maolic V, Férec C. 2004. Implication du gène CFTR dans la stérilité masculine associée à une absence de canaux déférents: Spectrum of CFTR mutations in congenital absence of the vas deferens. Immuno-Anal Biol Spéc. 19:343–350.
  • Fanen P, Ghanem N, Vidaud M, Besmond C, Martin J, Costes B, Plassa F, Goossens M. 1992. Molecular characterisation of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics. 13:770–776.
  • Fontaine E, Jardin A. 2001. Anomalies des organes génitaux internes masculins et retentissement sur la fertilité. Prog Uro. 11:729–732.
  • Fredj SH, Messaoud T, Templin C, Des Georges M, Fattoum S, Claustres M. 2009. Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisi. Genet test. 13:1–5.
  • Gaillard D, Clavel C, Bessaci-Kabouya K, Abély M. 2009. Les formes atténuées de la mucoviscidose: génétique - suivi prolongé nécessaire Mild cystic fibrosis: Genetics - extending follow-up is necessary. Arch Ped. 16:387–390.
  • G Noone P, R Knowles M. 2001. CFTR-Opathies: disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Resp Res. 2:328–332.
  • Larriba S, Bassas L, Giminez J, Ramos MD, Segura A, Nunes V, Estivill X, Casals T, Testicular CFTR. 1998. Testicular CFTR splice variants in patients with congenital absence of the vas deferens. J Hum Mol Genet. 11:1739–1744.
  • Le Maréchal C, Audrezet MP, Quere I, Raguenes O, Langonne S, Ferec C. 2001. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum Genet. 108:290–298.
  • Loumi O, Ferec C, Mercier B, Creff J, Fercot B, Denine R, Grangaud JP. 2008. CFTR mutations in the Algerian population. J Cys Fib. 7:54–59.
  • Middendorf RL, Bruce RC, Eckless RD, Grone DL, Roemer SC, Sloniker GD, Steffens DL, Sutter SL, Brumbaugh JA, Patony G. 1992. DNA sequencing using a versatile infrared laser scanner/electrophoresis apparatus. Electro. 13:487–494.
  • Rabti I, Legendre M, Niel F, Martin J, Soufir JC, Izard V, Costa C, Goossens M, Girodon E. 2007. Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Hum Rep. 22:1285–1291.
  • Radpour R, Gourabi H, Vosough Dizaj A, Holzgrev W, Yan Zhong X. 2008. Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility. J Androl. 29:506–513.
  • Radpour R, Sadighi Gilani MA, Gourabi H, Dizaj AV, Mollamohamadi S. 2006. Molecular analysis of the IVS8-T splice variant 5T and M470V exon 10missense polymorph in Iranian males with congenital bilateral absence of the vas deferens. Mol Hum Rep. 12:469–473.
  • Rich DP, Berger HA, Cheng SH, Travis SM, Saxena M, Smith AE, Welsh MJ. 1993. Regulation of the cystic fibrosis transmembrane conductance regulator Cl channel by negative charge in the R domain. J Biol Chem. 268:20259–20267.
  • Sambrook J, Fritsch EF, Maniatis T. 1989. Isolation of DNA from mammalian cells in Molecular cloning. New York: Laboratory Press.
  • Taulan M, Girardet A, Guittard C, Altieri JP, Templin C, Beroud CH, Des Georges M, Claustres M. 2007. Large genomic rearrangements in the CFTR gene contribute to CBAVD. BMC Med Genet. 8:22.
  • Yahia M, Naimi D. 2005. Recherche des mutations du gène CFTR chez les patients affectés par l'Atrésie Bilatérale des canaux différents (ABCD) dans l'Est et Sud Algérien. Sci Technol. 23:97–101.
  • Zielenski J, Markiewicz D, Chen HS, Schappert K, Seller A, Durie P, Corey M, Tsui LC. 1995. Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Mutat. 5:43–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.